Clinicopathologic analysis of patients with adult rhabdomyosarcoma

Cancer

Volumn 91, Issue 4, 2001, Pages 794-803

  Hawkins, William G ^a   Hoos, Axel ^a   Antonescu, Cristina R ^a   Urist, Marshall J ^a   Leung, Denis H Y ^a   Gold, Jason S ^a   Woodruff, James M ^a   Lewis, Jonathan J ^a   Brennan, Murray F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adult; Clinicopathologic; Rhabdomyosarcoma; Sarcoma; Survival

Indexed keywords

ADULT; ADULTHOOD; AGE; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CLINICAL TRIAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RHABDOMYOSARCOMA; SURVIVAL ANALYSIS;

EID: 0035864847     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010215)91:4<794::AID-CNCR1066>3.0.CO;2-Q     Document Type: Article

References (38)

1. Rhabdomyosarcoma: An overview
2. Rhabdomyosarcoma
3. Cancer statistics, 2000
4. Rhabdomyosarcoma of the extremities and trunk: Analysis of 150 patients treated by surgical resection
5. Rhabdomyosarcoma in middle-aged and elderly individuals
6. Pleomorphic rhabdomyosarcoma in adulthood. Analysis of 11 cases with definition of diagnostic criteria
7. Malignant fibrous histiocytoma of the extremity
8. Role of electron microscopy in the evaluation of soft tissue neoplasms, with emphasis on spindle cell and pleomorphic tumors
9. Pleomorphic rhabdomyosarcoma in adults: Immunohistochemistry as a tool for its diagnosis
10. The Intergroup Rhabdomyosarcoma Study-I. A final report
11. The Intergroup Rhabdomyosarcoma Study-II
12. The Third Intergroup Rhabdomyosarcoma Study
13. Is retroperitoneal lymph node dissection necessary for adult paratesticular rhabdomyosarcoma?
14. Embryonal rhabdomyosarcoma in adults
15. Pleomorphic rhabdomyosarcoma: A morphologic and immunohistochemical review of 45 cases with criteria of diagnosis
16. Nonparametric estimation from incomplete observations
17. Regression models and life tables
18. Combination chemotherapy (T-6) in the multidisciplinary treatment of Ewing's sarcoma
19. Intensification of preoperative chemotherapy for osteogenic sarcoma: Results of the Memorial Sloan-Kettering (T12) protocol
20. Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy
21. Pleomorphic soft tissue myogenic sarcomas of adulthood. A reappraisal in the mid-1990s
22. The effect of age at diagnosis on outcome in rhabdomyosarcoma
23. Extremity rhabdomyosarcoma: Biological principles, staging, and treatment
24. Pleomorphic rhabdomyosarcoma
25. Rhabdomyosarcoma in patients older than 40 years of age
26. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays
27. Detection of gene fusions in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction assay of archival samples
28. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma
29. Biology and therapy of pediatric rhabdomyosarcoma
30. Rhabdomyosarcoma. A new classification scheme related to prognosis
31. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: Implications for management
32. Soft tissue sarcomas
33. Adjuvant therapy for soft tissue sarcomas
34. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity
35. Long term results of a prospective randomized trial evaluating the role of adjuvant brachytherapy in soft tissue sarcoma
36. Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue
37. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas